Pharmaceutical Companies Increase Investment in Real-World Evidence Generation Roles for Post-Market Surveillance
Pharmaceutical firms are significantly expanding investment in roles dedicated to generating real-world evidence for post-market surveillance.
The story
in brief.
What happened, who it affects, and why it landed on our intelligence desk — in plain English, sixty seconds or less.
Pharmaceutical firms are significantly expanding investment in roles dedicated to generating real-world evidence for post-market surveillance. Driven by stringent regulatory demands for robust safety data following drug approval, this shift creates heightened demand for epidemiologists and data scientists. These professionals analyse patient outcomes to inform both drug development and policy decisions, marking a strategic pivot towards evidence-based post-approval monitoring within the industry.
Indicative index of skill mentions in professional job postings for the field this story moves (2019 = 1)
What this means
for your career.
Every headline redistributes opportunity. Here is who this one rewards — and how to be on the right side of it.
This shift elevates the value of epidemiological analysis and advanced data science skills. If you work in pharma or healthcare analytics, you must prioritise expertise in real-world data interpretation. Regulators increasingly rely on these insights for safety monitoring, making your ability to derive actionable intelligence from patient outcomes critical. Smart professionals should immediately upskill in statistical modelling and regulatory compliance frameworks. Focus on understanding how real-world evidence influences policy decisions. By mastering these competencies, you position yourself as indispensable for post-market surveillance teams, ensuring career resilience against evolving industry standards and regulatory expectations.
For this story, the fields that convert it into pay are Data Science, AI in Pharmaceuticals, Compliance And Governance and Advanced SQL For Data Analysis — exactly the programmes matched below. The chart shows the indicative salary uplift certified professionals report in each of those fields; every one of them is a click away, from £79, finishing in as few as 20 days.
Indicative ranges from published continuing-education salary studies, by field — each field is a recommended course below
Enrol in these
to benefit.
These programmes position you for exactly this shift — online, self-paced, and finishing with a verifiable certificate you can share the day you pass.
Best match
Certificate in Data Science
Recommended
Certificate in AI in Pharmaceuticals
Recommended
Certificate in Compliance And Governance
Recommended
Certificate in Advanced SQL For Data Analysis
Launch pricing shown against standard certificate value. The fee you see today is the fee you lock in.
Read the news. Then outrun it.
Every OnlineUni programme is online, self-paced and from £79 — so a headline today can be your credential this month.